Drug Class: Non-biologic small molecule
Non-biologic small molecule drugs are orally administered therapies that reduce inflammation by targeting specific intracellular signaling pathways involved in immune cell activation; examples include tofacitinib (Xeljanz), a Janus kinase (JAK) inhibitor, and ozanimod (Zeposia), a sphingosine 1-phosphate (S1P) receptor modulator.